DrugBiological
Figitumumab clinical trials
Also written CP-751,871.
- studies test it
- 19
- open now
- 0
- in phase 3
- 3
- first study started
- 2003
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
18 studies that test it; most in 2009 (5)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 7
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 2
Pfizer (17) · Suzanne George, MD (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)
Often tested with
Tested in the same studies.
Everolimus (1) · Docetaxel (1) · Cisplatin (1) · Gemcitabine (1) · Sunitinib (1) · Pegvisomant (1)
Studies
Open first, then newest update. How each study uses figitumumab is read from its arms, and is right about nine times in ten.
Testing it · 19
- A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck CarcinomaTerminatedPhase 2Cliniques universitaires Saint-Luc- Université Catholique de LouvainNCT00872404Written as CP-751,871
- Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of TumorsCompletedPhase 1/2PfizerNCT00560235Written as CP-751,871
- Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast CancerTerminatedPhase 2PfizerNCT00372996Written as CP-751,871
- Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast CancerWithdrawnPhase 2PfizerNCT00678626Written as CP-751,871
- CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By SurgeryWithdrawnPhase 1PfizerNCT00635245Written as figitumumab
- Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung CancerWithdrawnPhase 3PfizerNCT00907504Written as CP-751,871
- Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid TumorsTerminatedPhase 1PfizerNCT00729833Written as CP-751,871
- Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma HistologyTerminatedPhase 3PfizerNCT00596830Written as CP-751,871 (Figitumumab)
- Study Of Anti-IGF-IR CP-751,871 In Patients With Solid TumorsCompletedPhase 1PfizerNCT00474760Written as CP-751,871
- Figitumumab Combined With Pegvisomant For Advanced Solid TumorsTerminatedPhase 1PfizerNCT00976508Written as figitumumab
- RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant NeoplasmsCompletedPhase 1Suzanne George, MDNCT00927966Written as CP-751,871
- CP-751,871 In Combination With Docetaxel In Advance Non-hematologic MalignanciesCompletedPhase 1PfizerNCT01653158Written as CP-751,871
- Trial Of CP-751, 871 And Erlotinib In Refractory Lung CancerTerminatedPhase 3PfizerNCT00673049Written as CP 751,871 (Figitumumab)
- Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer TreatmentsCompletedPhase 2PfizerNCT00560560Written as CP-751, 871
- A Pharmacokinetic And QT Study Of CP-751,871 In Healthy SubjectsTerminatedPhase 1PfizerNCT00926263Written as CP-751,871
- Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)CompletedPhase 2PfizerNCT00313781Written as CP-751,871
- Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung CancerCompletedPhase 1PfizerNCT00560573Written as CP-751,871
- CP-751,871 Treatment For Patients With Multiple MyelomaCompletedPhase 1PfizerNCT01536145Written as CP-751,871
- A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung CancerTerminatedPhase 2PfizerNCT00977561Written as figitumumab
Given in every arm · 1 — figitumumab is usual care beside what is tested
Codes
What other systems call figitumumab · ClinicalTrials.gg INT005197
- MeSH (NLM) C525021figitumumabConfirmed NLM, Wikidata
- UNII (FDA) VE267FC2UBFIGITUMUMABConfirmed FDA, NLM, Wikidata
- Wikidata Q430194figitumumabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C52187FigitumumabOne source FDA
- DrugBank DB11685One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C525021 | figitumumab | Confirmed NLM, Wikidata |
| UNII (FDA) | VE267FC2UB | FIGITUMUMAB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q430194 | figitumumab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C52187 | Figitumumab | One source FDA |
| DrugBank | DB11685 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.